News and Announcements
KERB launches new website as it moves into another six European countries
- Published June 06, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Kerb, the Australian parking app which is aiming to become the global “Airbnb for parking” has just announced its launch into Italy, France, Spain, Portugal, Germany, and the Netherlands. This continues its expansion through Europe – where it is also live and gaining traction in the UK and Ireland – and coincides with the launch of a brand new, multi-lingual version of the Kerb website at www.kerb.works.
Kerb has recently attracted an additional 3 investors, taking its total to 11, and was featured on BBC World News and BBC London News in May 2018. It has raised USD1.4m of its Seed round target of USD2.5m, which it hopes to have reached by end of July 2018. Investors who are still interested in being part of this exciting business should download the Kerb investor manual from this link, or from the Kerb profile page on the Wholesale Investor website.
About Kerb
By unlocking under-utilised space under apartment blocks, in driveways, behind stores and on top of buildings across Developed and Developing countries, Kerb is making parking cheaper, quicker and less stressful for tens of thousands of commuters worldwide. It is also a way for individuals, churches, schools, hotels and many other organisations to make money from their empty spaces.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
